Gastrointestinal Endoscopy Devices – Market Insights – United States

The GI endoscopy device market in the US has experienced short-term challenges due to the COVID-19 pandemic. Nevertheless, there are signs of a robust recovery and projected moderate expansion until 2032. New treatment and screening guidelines, along with the availability of alternative tests, are expected to drive growth of procedure volumes across the country. The market is also witnessing the adoption of single-use duodenoscopes to address contamination concerns, although recent developments have highlighted issues with these components. Furthermore, the growing integration of AI in GI videoscope systems is poised to foster overall market growth. Despite these positive trends, factors such as accelerated hospital consolidation, reimbursement changes, and the shift toward value-based care may impose limitations on the market’s overall growth trajectory.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in the US from 2019 to 2032.

The COVID-19 pandemic has negatively affected the GI endoscopy device market.

To what degree has the GI endoscopy device market in the US been influenced by the COVID-19 pandemic?

Which procedures have been most affected during the pandemic?

How quickly are procedure volumes, sales, and revenues recovering?

How has the pandemic impacted the adoption of innovative technologies such as capsule endoscopes?

CRC screening recommendation updates, recent expansion of Medicare coverage for colorectal cancer screening tests, and the increased availability of alternative tests will support colonoscopy procedure volumes.

What are the latest CRC screening recommendations? How will they impact overall procedure volumes?

How have recent modifications in Medicare coverage for colorectal cancer screening tests affected the number of colonoscopy procedures performed?

To what extent will colonoscopy procedure volumes be impacted by alternative CRC tests?

Which device markets will be most impacted by updated screening recommendations, changes in coverage, and screening innovations?

Concerns surrounding the contamination of reprocessed duodenoscopes has led to an increase in the uptake of single-use duodenoscopes

Which competitors are currently able to market single-use duodenoscopes?

What regulatory efforts are being made to support the adoption of single-use duodenoscopes?

Following the duodenoscope outbreak, several manufacturers opted to adopt models with disposable components to minimize the risk of infection. However, recent developments have revealed issues with these disposable components too.

How has the FDA responded to the issues with duodenoscopes with disposable tips, and what action are companies taking in response?

What impact has the discovery of problems with disposable duodenoscope tips had on the GI endoscopy device market?

The increasing integration of AI in GI videoscope systems will support overall growth in the GI endoscopy market

How is growing integration of AI impacting screening and procedure volumes?

What AI-enabled videoscope systems are currently available in the US?

Which companies are looking to offer AI capabilities in coming years?